Product fact sheet
Culturelle Digestive Daily Probiotic Capsules
Evidence-aware Culturelle Digestive Daily fact sheet for LGG, including viable-count labeling, safety context and a failed antimicrobial-resistance prevention trial.
Contains the extensively studied LGG strain and guarantees viable count through expiration, but one randomized hospital trial found LGG did not prevent acquisition of antimicrobial-resistant organisms; evidence for one use must not be recycled into another.
People who want a named probiotic strain and expiration-date CFU guarantee, Readers comparing strain-level evidence rather than generic 'gut health' claims
Using probiotics to prevent antimicrobial-resistant colonization, Severely ill or immunocompromised people without clinician guidance
Key tradeoff: Strong strain identity and viability documentation, but no probiotic strain is universally effective across conditions.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
Culturelle Digestive Daily contains Lactobacillus rhamnosus GG (LGG), a named probiotic strain with a large research literature. The current product page also states a viable count through expiration, which is more decision-useful than a count reported only at manufacture.
A specific claim that failed
In a randomized trial of hospitalized adults receiving broad-spectrum antibiotics, LGG did not prevent acquisition of antimicrobial-resistant organisms and did not accelerate loss of colonization.
That is a useful negative result. Consumers should steer clear of claims that this strain has been proven to prevent antimicrobial-resistant colonization in that setting.
It would be equally wrong to turn that result into a universal statement that LGG is ineffective for every other condition. Probiotic evidence is strain-, dose-, population- and endpoint-specific.
Safety context
NIH ODS notes that probiotics are generally well tolerated in healthy people, while rare serious infections have occurred in people with severe illness or compromised immune systems. That changes the risk-benefit calculation in medically vulnerable users.
What to compare
Check the exact strain, CFU through expiration, storage requirements and whether evidence for the intended use actually involves LGG at a comparable dose.
See Probiotics, Prebiotics & Digestive Enzymes for the evidence framework.
Formula facts
Ingredients, actives and label details
- Key strain
- Lactobacillus rhamnosus GG (LGG) Basis: Manufacturer Source: Culturelle Digestive Daily Probiotic Capsules
- Viable count
- 10 billion CFU per serving stated; manufacturer says count is guaranteed through expiration Basis: Manufacturer Source: Culturelle Digestive Daily Probiotic Capsules
- Failed specific use
- LGG did not reduce acquisition of antimicrobial-resistant organisms in 88 hospitalized adults receiving broad-spectrum antibiotics Basis: Randomized controlled trial negative Steer clear of this specific prevention claim; this is not a blanket failure of LGG. Source: A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization
- Safety context
- Extra caution is warranted in people who are severely ill or immunocompromised Basis: Government evidence review Source: Probiotics - Health Professional Fact Sheet
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Safety first
What should make you slow down?
Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
Source trail
Primary documents and supporting evidence
- Culturelle Digestive Daily Probiotic CapsulesCulturelle · Manufacturer · retrieved 2026-08-11
- A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonizationInfection Control & Hospital Epidemiology / PubMed · Randomized controlled trial negative · retrieved 2026-08-11
- Probiotics - Health Professional Fact SheetNIH Office of Dietary Supplements · Government evidence review · retrieved 2026-08-11